Serotonin and the Neuroendocrine Regulation of the Hypothalamic-Pituitary-Adrenal Axis in Health and Disease

Vitamins and Hormones

Volumn 66, Issue , 2003, Pages 189-255

  Hanley, N R Sullivan ^a   Van de Kar, L D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ADRENAL GLAND; ANIMAL; ANXIETY; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; DEPRESSION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NEUROSECRETION; PHYSIOLOGY; REVIEW; STRESS;

ADRENAL GLANDS; ANIMALS; ANXIETY; CIRCADIAN RHYTHM; DEPRESSION; FATIGUE SYNDROME, CHRONIC; HUMANS; HYPOTHALAMUS; NEUROSECRETORY SYSTEMS; PITUITARY GLAND; SEROTONIN; STRESS;

EID: 0042307335     PISSN: 00836729     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0083-6729(03)01006-9     Document Type: Article

References (483)

1. K Abe J Kroning M.A Greer V Critchlow Effects of destruction of the suprachiasmatic nuclei on the circadian rhythms in plasma corticosterone, body temperature, feeding and plasma thyrotropin Neuroendocrinology 29 1979 119 131
2. G Aguilera J.P Harwood J.X Wilson J Morell J.H Brown K.J Catt Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells J. Biol. Chem. 258 1983 8039 8045
3. S.F Akana K.A Scribner M.J Bradbury A.M Strack C.D Walker M.F Dallman Feedback sensitivity of the rat hypothalamo–pituitary–adrenal axis and its capacity to adjust to exogenous corticosterone Endocrinology 131 1992 585 594
4. J Akiyoshi H Kuranaga K Tsuchiyama H Nagayama Circadian rhythm of serotonin receptor in rat brain Pharmacol. Biochem. Behav. 32 1989 491 493
5. P Albrecht M.B Visscher J.J Bittner F Halberg Daily changes in 5-hydroxytryptamine concentrations in mouse brain Proc. Soc. Exp. Biol. Med. 92 1956 703 711
6. R.H Alper Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat Neuroendocrinology 51 1990 255 260
7. A.H Amin T.B.B Crawford J.H Gaddum The distribution of substance P and 5-hydroxytryptamine in the central system of the dog J. Physiol. 126 1954 596 618
8. A Anand D.S Charney P.L Delgado C.J Mcdougle G.R Heninger L.H Price Neuroendocrine and behavioral responses to intravenous m -chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects Am. J. Psychiatry 151 1994 1626 1630
9. G.H Anderson E.T Li S.P Anthony L.T Ng R Bialik Dissociation between plasma and brain amino acid profiles and short-term food intake in the rat Am. J. Physiol. 266 1994 R1675 R1686
10. I.M Anderson C Mortimore 5-HT and human anxiety: Evidence from studies using acute tryptophan depletion Adv. Exp. Med. Biol. 467 1999 43 55
11. I.M Anderson J.F.W Deakin H.E.J Miller The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers Psychopharmacology (Berl.) 128 1996 74 82
12. W.G Anderson J.M Conlon N Hazon Characterization of the endogenous intestinal peptide that stimulates the rectal gland of Scyliorhinus canicula Am. J. Physiol. 268 1995 R1359 R1364
13. A Angeli G Gatti R Masera Chronobiology of the hypothalamic–pituitary–adrenal and renin–angiotensin–aldosterone systems Y Touitou E Haus “Biologic Rhythms in Clinical and Laboratory Medicine” 1992 Springer-Verlag Berlin 292 314
14. 1c receptors in rat brain J. Pharmacol. Exp. Ther. 255 1990 843 857
15. A Appels F.W Bar J Bar C Bruggeman M de Baets Inflammation, depressive symptomology, and coronary artery disease Psychosom. Med. 62 2000 601 605
16. L Arborelius M.J Owens P.M Plotsky C.B Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J. Endocrinol. 160 1999 1 12
17. S.V Argyropoulos J.J Sandford D.J Nutt The psychobiology of anxiolytic drugs. 2. Pharmacological treatments of anxiety Pharmacol. Ther. 88 2000 213 227
18. A Armario C Garcia-Marquez Tricyclic antidepressants activate the pituitary–adrenal axis in the rat: Tolerance to repeated drug administration Eur. J. Pharmacol. 140 1987 239 244
19. J.L Arriza R.B Simerly L.W Swanson R.M Evans The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response Neuron 1 1988 887 900
20. M.C Austin J.L Rhodes D.A Lewis Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem Neuropsychopharmacology 17 1997 326 341
21. E.C Azmitia M Segal An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat J. Comp. Neurol. 179 1978 641 668
22. A.J Baertschi D.G Ward D.S Gann Role of atrial receptors in the control of ACTH Am. J. Physiol. 231 1976 692 699
23. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses Endocrinology 134 1994 1127 1131
24. G Bagdy K Szemeredi B Kanyicska D.L Murphy Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m -chlorophenylpiperazine in conscious rats J. Pharmacol. Exp. Ther. 250 1989 72 78
25. G Bagdy A.E Calogero K Szemeredi G.P Chrousos P.W Gold Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH Regul. Pept. 31 1990 83 92
26. T.W Bailey J.A DiMicco Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 2001 R8 R15
27. R.A Baker M Herkenham Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat J. Comp. Neurol. 358 1995 518 530
28. A.M.O Bakheit P.O Behan T.G Dinan C.E Gray V O'Keane Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
29. T Ban T Sugawara T., Jr Ban T Arikuni Y Shiotani Relationship between the medial longitudinal fasciculus and the dorsal longitudinal fasciculus Med. J. Osaka Univ. 25 1975 79 94
30. J Bancroft A Cook D Davidson J Bennie G Goodwin Blunting of neuroendocrine responses to infusion of l -tryptophan in women with perimenstrual mood change Psychol. Med. 21 1991 305 312
31. Z Banky B Halasz G Nagy Circadian corticosterone rhythm did not develop in rats seven weeks after destruction with 5,7-dihydroxytryptamine of the serotoninergic nerve terminals in the suprachiasmatic nucleus at the age of 16 days Brain Res. 369 1986 119 124
32. N.M Barnes T Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
33. J Bearn T Allain P Coskeran N Munro J Butler A McGregor S Wessely Neuroendocrine responses to d -fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome Biol. Psychiatry 37 1995 245 252
34. S Beaulieu T DiPaolo N Barden Control of ACTH secretion by the central nucleus of the amygdala, implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism Neuroendocrinology 44 1986 247 254
35. 3H]aspartate labelling of possible excitatory amino acid inputs Neuroscience 37 1990 77 100
36. 1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects Clin. Pharmacol. Ther. 63 1998 428 436
37. L.L Bernardis The dorsomedial hypothalamic nucleus in autonomic and neuroendocrine homeostasis Can. J. Neurol. Sci. 2 1975 45 60
38. S Bhatnagar M Dallman Neuroanatomical basis for facilitation of hypothalamic–pituitary–adrenal responses to a novel stressor after chronic stress Neuroscience 84 1998 1025 1039
39. A.N Bhattacharya B.H Marks Effects of α methyl tyrosine and p -chlorophenylalanine on the regulation of ACTH secretion Neuroendocrinology 6 1970 49 55
40. M Bianchi P Sacerdote A.E Panerai Fluoxetine reduces inflammatory edema in the rat: Involvement of the pituitary–adrenal axis Eur. J. Pharmacol. 263 1994 81 84
41. P Blier Pharmacology of rapid-onset antidepressant treatment strategies J. Clin. Psychiatry 62 Suppl. 15 2001 12 17
42. P Blier C Bouchard Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs Br. J. Pharmacol. 113 1994 485 495
43. 1A agonist gepirone, electrophysiological studies in the rat brain Synapse 1 1987 470 480
44. P Blier C de Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226
45. 1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system Neuropsychopharmacology 15 1996 213 214
46. 1A receptors exhibit different electrophysiological properties. II. Effects of pertussis and cholera toxins Soc. Neurosci. Abstr. 16 1990
47. M.C Boadle-Biber V.B Singh K.C Corley T.-H Phan R.P Dilts Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat Brain Res. 628 1993 105 114
48. S Boeles C Williams G.M Campling E.M Goodall P.J Cowen Sumatriptan decreases food intake and increases plasma growth hormone in healthy women Psychopharmacology( Berl. ) 129 1997 179 182
49. F.G Boess I.L Martin Molecular biology of 5-HT receptors Neuropharmacology 33 1994 275 317
50. 1A autoreceptors Neuropharmacology 32 1993 527 534
51. J Born W Kern K Bieber G Fehm-Wolfsdorf M Schiebe H.L Fehm Night-time plasma cortisol secretion is associated with specific sleep stages Biol. Psychiatry 21 1986 1415 1424
52. 1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe Eur. J. Pharmacol. 333 1997 147 157
53. 1A receptor-mediated feedback: A microdialysis study in the amygdala J. Neurochem. 76 2001 1645 1653
54. P Boyer Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr. Scand. Suppl. 406 2000 24 29
55. M Bradbury M.F Dallman Effects of hippocampal type 1 and type 2 glucocorticoid antagonists on ACTH levels in the PM “Program of the 19th Annual Meeting of the Society for Neuroscience,” Phoenix, AZ 1989 716
56. M.J Bradbury S.F Akana C.S Cascio N Lvein L Jacobson M.F Dallman Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain J. Steroid Biochem. Mol. Biol. 40 1991 133 142
57. M.J Bradbury S.F Akana M.F Dallman Roles of type I and II glucocorticoid receptors in regulation of basal activity in the hypothalamo–pituitary–adrenal axis during the diurnal trough and the peak: Evidence for a nonadditive effect of combined receptor occupation Endocrinology 134 1994 1286 1296
58. J.D Bremner R.B Innis R.M Salomon L.H Staib C.K Ng H.L Miller R.A Bronen J.H Krystal J Duncan D Rich L.H Price R Malison H Dey R Soufer D.S Charney Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse Arch. Gen. Psychiatry 54 1997 364 374
59. J.D Bremner J Licinio A Darnell J.H Krystal M.J Owens S.M Southwick C.B Nemeroff D.S Charney Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder Am. J. Psychiatry 154 1997 624 629
60. A Broocks B Bandelow A George C Jestrabeck M Optiz U Bartmann C.H Gleiter I Meineke I.S Roed E Ruther G Hajak Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder Int. Clin. Psychopharmacol. 15 2000 153 161
61. T.O Bruhn P.M Plotsky W.W Vale Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: Studies on the adrenocorticotropin response to ether stress and exogenous CRF Endocrinology 114 1984 57 62
62. J.F Bruni R.L Hawkins S.S.C Yen Serotonergic mechanism in the control of β-endorphin and ACTH release in male rats Life Sci. 30 1982 1247 1254
63. R.M Buijs J Wortel J.J Van Heerikhuize M.G.P Feenstra G.J ter Horst H.J Romijn A Kalsbeek Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway Eur. J. Neurosci. 11 1999 1535 1544
64. A.E Calogero R Bernardini A.N Margioris G Bagdy W.T Gallucci L Tamarkin T.P Tomai Effect of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami Peptides 10 1989 189 200
65. 3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures Eur. J. Endocrinol. 133 1995 251 254
66. S Campeau M Davis Involvement of subcortical and cortical afferents to the lateral nucleus of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli J. Neurosci. 15 1995 2312 2327
67. S Campeau M Davis Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli J. Neurosci. 15 1995 2301 2311
68. N.S Canteras L.W Swanson Projections of the ventral subiculum to the amygdala, septum, and hypothalamus: A PHAL anterograde tract-tracing study in the rat J. Comp. Neurol. 324 1992 180 194
69. 1C sites Eur. J. Pharmacol. 191 1990 93 96
70. A Carlsson B Falck N Hillarp Cellular localization of brain monoamines Acta Physiol. Scand. 56 1962 1 27
71. 1A receptors control 5-HT release in the rat medial prefrontal cortex Neuroreport 10 1999 1441 1445
72. 1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(di- n -propylamino)tetralin: Microdialysis and autoradiographic studies in rat brain J. Neurochem. 72 1999 262 272
73. W.J Cassano Jr. A.P D'Mello Acute stress-induced facilitation of the hypothalamic–pituitary–adrenal axis: Evidence for the roles of stressor duration and serotonin Neuroendocrinology 74 2001 167 177
74. A Ceci A Baschirotto F Borsini The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex Neuropharmacology 33 1994 709 713
75. A, and glutamate receptors J. Neurosci. 21 2001 9917 9929
76. 1A receptor mRNA expression J. Neurosci. 13 1993 914 923
77. 2 receptor down-regulation Eur. J. Pharmacol. 249 1993 117 120
78. W.P Chapman H.R Schroeder G Geyer M.A.B Brazier C Fager J.L Poppen H.C Solomon P.I Yakovlev Physiological evidence concerning importance of the amygdaloid nuclear region in the integration of circulatory function and emotion in man Science 120 1954 949 950
79. D.S Charney W.K Goodman L.H Price S.W Wood S.A Rasmussen G.R Heninger Serotonin function disorder obsessive-compulsive disorder Arch. Gen. Psychiatry 45 1988 177 185
80. A.J Cleare J Bearn T Allain A McGregor S Wessely R.M Murray V O'Keane Contrasting neuroendocrine responses in depression and chronic fatigue syndrome J. Affect. Disord. 34 1995 283 289
81. A.J Cleare R.M Murray V O'Keane Reduced prolactin and cortisol responses to d -fenfluramine in depressed compared to healthy matched control subjects Neuropsychopharmacology 14 1996 349 354
82. A.J Cleare R.M Murray V O'Keane Assessment of serotonergic function in major depression using d -fenfluramine: Relation to clinical variables and antidepressant response Biol. Psychiatry 44 1998 555 561
83. 7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function J. Neurochem. 71 1998 1271 1279
84. 7 receptors Br. J. Pharmacol. 127 1999 236 242
85. E.F Coccaro R.J Kavoussi T.B Cooper R.L Hauger Hormonal responses to d - and d, l-fenfluramine in healthy human subjects Neuropsychopharmacology 15 1996 595 607
86. V Coiro R Volpi C Davoli G Caffarri P Chiodera Influence of age on the GH response to sumatriptan administration in man J. Neural Transm. Gen. Sect. 101 1995 195 200
87. R.D Cone K.G Mountjoy L.S Robbins J.H Nadeau K.R Johnson L Roselli-Rehfuss M.T Mortrud Cloning and functional characterization of a family of receptors for the melanotropic peptides Ann. N.Y. Acad. Sci. 680 1993 342 363
88. N Conforti S Feldman Effects of dorsal fornix section and hippocampectomy on adrenocortical responses to sensory stimulation in the rat Neuroendocrinology 22 1976 1 7
89. L.C Conrad D.W Pfaff Efferents from medial basal forebrain and hypothalamus in the rat. II. An autoradiographic study of the anterior hypothalamus J. Comp. Neurol. 169 1976 221 261
90. W.H Coryell D.W Black M.W Kelly R Noyes Jr. HPA axis disturbance in obsessive-compulsive disorder Psychiatry Res. 30 1989 243 251
91. D.S Cowley D.L Dunner Response to sodium lactate in panic disorder: Relationship to presenting clinical variables Psychiatry Res. 25 1988 253 259
92. D.S Cowley S.R Dager J McClellan P.P Roy-Byrne D.L Dunner Response to lactate infusion in generalized anxiety disorder Biol. Psychiatry 24 1988 409 414
93. W.E Cullinan J.P Herman S.J Watson Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis J. Comp. Neurol. 332 1993 1 20
94. G.C Curtis J.L Abelson P.W Gold Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: Changes in panic disorder and effects of alprazolam treatment Biol. Psychiatry 41 1997 76 85
95. J.F Czachura K Rasmussen Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat Naunyn Schmiedebergs Arch. Pharmacol. 362 2000 266 275
96. A Dahlstrom K Fuxe Localization of monoamines in the lower brain stem Experientia 20 1964 398 399
97. M.F Dallman M.T Jones Glucocorticoid feedback control of ACTH secretion, effect of stress-induced corticosterone secretion on subsequent stress responses in the rat Endocrinology 92 1973 1367 1375
98. M.F Dallman N Levin C.S Cascio S.F Akana L Jacobson R.W Kuhn Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by glucocorticoids is mediated via type I corticosterone-preferring receptors Endocrinology 124 1989 2844 2850
99. M Davis P.J Whalen The amygdala, vigilance and emotion Mol. Psychiatry 6 2001 13 34
100. M Davis D Rainnie M Cassell Neurotransmission in the rat amygdala related to fear and anxiety Trends Neurosci. 17 1994 208 214
101. L.A Dawson H.Q Nguyen D.L Smith L.E Schechter Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex J. Psychopharmacol. 16 2002 145 152
102. T Deak K.T Nguyen C.S Cotter M Fleshner L.R Watkins S.F Maier R.L Spencer Long-term changes in mineralocorticoid and glucocorticoid receptor occupancy following exposure to an acute stressor Brain Res. 847 1999 211 220
103. E.R De Kloet M.S Oitzl M Joels Functional implications of brain glucocorticoid receptor diversity Cell. Mol. Neurobiol. 13 1993 433 455
104. E.R De Kloet E Vreugdenhil M.S Oitzl M Joels Brain glucocorticoid receptor balance in health and disease Endocr. Rev. 19 1998 269 301
105. R De Kloet G Wallach B.S McEwen Differences in corticosterone and dexamethasone binding to rat brain and pituitary Endocrinology 96 1975 598 609
106. P.L Delgado Depression: The case for a monoamine deficiency J. Clin. Psychiatry 61 Suppl. 6 2000 7 11
107. P.L Delgado D.S Charney L.H Price G.K Aghajanian H Landis G.R Heninger Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch. Gen. Psychiatry 47 1990 411 418
108. P.L Delgado L.H Price H.L Miller R.M Salomon G.K Aghajanian G.R Heninger D.S Charney Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug-free depressed patients Arch. Gen. Psychiatry 51 1994 865 874
109. M.A Demitrack Neuroendocrine correlates of chronic fatigue syndrome: A brief review J. Psychiatr. Res. 31 1997 69 82
110. M.A Demitrack J.K Dale S.E Straus L Laue S.J Listwak M.J Kruesi G.P Chrousos P.W Gold Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome J. Clin. Endocrinol. Metab. 73 1991 1224 1234
111. M.A Demitrack P.W Gold J.K Dale D.D Krahn M.A Kling S.E Straus Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings Biol. Psychiatry 32 1992 1065 1077
112. C de Montigny Y Chaput P Blier Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers J. Clin. Psychiatry 51 Suppl. B 1990 4 8
113. 7 receptor Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 90 99
114. A Di Lauro C.P Giannini G Muscettola A.M Greco P de Franciscis No circadian rhythms of serotoninergic, β-adrenergic and imipramine binding sites in rat brain regions Chronobiol. Int. 3 1986 123 126
115. J.A DiMicco E.H Stotz-Potter A.J Monroe S.M Morin Role of the dorsomedial hypothalamus in the cardiovascular response to stress Clin. Exp. Pharmacol. Physiol. 23 1996 171 176
116. J.A DiMicco B.C Samuels M.V Zaretskaia D.V Zaretsky The dorsomedial hypothalamus and the response to stress: Part renaissance, part revolution Pharmacol. Biochem. Behav. 71 2002 469 480
117. T.G Dinan Serotonin and the regulation of hypothalamic–pituitary–adrenal axis function Life Sci. 58 1996 1683 1694
118. T.G Dinan T Majeed E Lavelle L.V Scott C Berti P Behan Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome Psychoneuroendocrinology 22 1997 261 267
119. B.N Dixit J.P Buckley Circadian changes in brain 5-hydroxytryptamine and plasma corticosterone in the rat Life Sci. 6 1967 755 758
120. B.N Dixit J.P Buckley Brain 5-hydroxytryptamine and anterior pituitary activation by stress Neuroendocrinology 4 1969 32 41
121. P Driscoll J Dedek J.R Martin B Zivkovic Two-way avoidance and acute shock stress induced alterations of regional noradrenergic, dopaminergic and serotonergic activity in Roman high- and low-avoidance rats Life Sci. 33 1983 1719 1725
122. T.E Dudley L.A Dinardo J.D Glass In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus J. Neurophysiol. 81 1999 1469 1477
123. A.J Dunn Changes in plasma and brain tryptophan and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress Life Sci. 42 1988 1847 1853
124. A.J Dunn Brain catecholaminergic and tryptophan responses to restraint are attenuated by nitric oxide synthase inhibition Neurochem. Int. 33 1999 551 557
125. A.J Dunn Footshock-induced changes in brain catecholamines and indoleamines are not mediated by CRF or ACTH Neurochem. Int. 37 2000 61 69
126. 1–24 in normal and hypophysectomized rabbits Biochem. Biophys. Res. Commun. 96 1980 447 456
127. 1-like agonist on pituitary adrenal function in healthy volunteers B. J. Clin. Pharmacol. 33 1992 538P
128. 1 receptor agonist, on circulating ACTH and cortisol concentrations in man Br. J. Clin. Pharmacol. 39 1995 389 395
129. 1-like receptors Clin. Endocrinol. ( Oxf .). 40 1994 211 214
130. F Fadda Tryptophan-free diets: A physiological tool to study brain serotonin function News Physiol. Sci. 15 2000 260 264
131. B Falck N Hillarp G Thieme A Thorp Fluorescence of catecholamines and related compounds with formaldehyde J. Histochem. Cytochem. 10 1962 348 354
132. V.S Fang B.J Tricou A Robertson H.Y Meltzer Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone suppression test Life Sci. 29 1981 931 938
133. S Feldman J Weidenfeld Neural mechanisms involved in the glucocorticoid feedback effects on the hypothalamo–pituitary–adrenal axis Prog. Neurobiol. 45 1995 129 141
134. S Feldman J Weidenfeld The excitatory effects of the amygdala on hypothalamo–pituitary–adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41 Brain Res. Bull. 45 1998 389 393
135. S Feldman N Conforti R.A Siegel Adrenocortical responses following limbic stimulation in rats with hypothalamic deafferentations Neuroendocrinology 35 1982 205 211
136. S Feldman N Conforti E Melamed Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion Brain Res. Bull. 18 1987 165 168
137. S Feldman D Saphier N Conforti Hypothalamic afferent connections mediating adrenocortical responses that follow hippocampal stimulation Exp. Neurol. 98 1987 103 109
138. S Feldman M.E Newman E Gur J Weidenfeld Role of serotonin in the amygdala in hypothalamo–pituitary–adrenocortical responses Neuroreport 9 1998 2007 2009
139. M Fendt M.S Fanselow The neuroanatomical and neurochemical basis of conditioned fear Neurosci. Biobehav. Rev. 23 1999 743 760
140. C Fernandes C.R Mckittrick S.E File B.S McEwen Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety Psychoneuroendocrinology 22 1997 477 491
141. G Ferraro M.E Montalbano P Sardo V La Grutta Lateral habenular influence on dorsal raphe neurons Brain Res. Bull. 41 1996 47 52
142. C.T Fischette B.R Komisaruk H.M Edinger H.H Feder A Siegel Differential fornix ablations and the circadian rhythmicity of adrenal glucocorticoid secretion Brain Res. 195 1980 373 387
143. E Florey E Florey Z. Naturforsch. 9b 1954 58 68
144. C.M Forchetti J.L Meek Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus Brain Res. 206 1981 208 212
145. J.R Fozard Basic mechanisms of antimigrane drugs M Critchley “Advances in Neurology” 1982 Raven Press New York 295 357
146. R Franceschini A Cataldi A Garibaldi P Cianciosi A Scordamaglia T Barreca E Rolandi The effects of sumatriptan on pituitary secretion in man Neuropharmacology 33 1994 235 239
147. K Fukuda S.E Straus I Hickie M.C Sharpe J.G Dobbins A Komaroff The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group Ann. Intern. Med. 121 1994 953 959
148. R.W Fuller Effects of p -chloroamphetamine on brain serotonin neurons Neurochem. Res. 17 1992 449 456
149. R.W Fuller The involvement of serotonin in regulation of pituitary-adrenocortical function L Martini W.F Ganong “Frontiers in Neuroendocrinology” 1992 Raven Press New York 250 270
150. R.W Fuller Serotonin receptors involved in regulation of pituitary–adrenocortical function in rats Behav. Brain Res. 73 1996 215 219
151. R.W Fuller H.D Snoddy Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats Endocr. Res. Commun. 4 1977 11 23
152. R.W Fuller H.D Snoddy Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists Neuroendocrinology 52 1990 206 211
153. R.W Fuller H.D Snoddy B.B Molloy Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus–pituitary–adrenal function in rats Life Sci. 19 1976 337 346
154. S Gaillet G Alonso R Le Borgne G Barbanel F Malaval I Assenmacher A Szafarczyk Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids Neuroendocrinology 58 1993 408 419
155. D.W Gallager Benzodiazepines: Potentiation of a GABA inhibitory response in the dorsal raphe nucleus Eur. J. Pharmacol. 49 1978 133 143
156. D.T George C Benkelfat R.R Rawlings M.J Eckardt M.J Phillips D.J Nutt D Wynne D.L Murphy M Linnoila Behavioral and neuroendocrine responses to m -chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects Am. J. Psychiatry 154 1997 81 87
157. J.M George D.M Jacobowitz Localization of vasopressin in discrete areas of the rat hypothalamus Brain Res. 93 1975 363 366
158. M Germine A.W Goddard S.W Woods D.S Charney G.R Heninger Anger and anxiety responses to m -chlorophenylpiperazine in generalized anxiety disorder Biol. Psychiatry 32 1992 457 461
159. D Gervasoni C Peyron C Rampon B Barbagli G Chouvet N Urbain P Fort P.H Luppi Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons J. Neurosci. 20 2000 4217 4225
160. J.L Gibbons Cortisol secretion rate in depressive illness Arch. Gen. Psychiatry 10 1964 572 575
161. V Giguere F Labrie Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture Endocrinology 111 1982 1752 1754
162. J.C Gilbert L.I Goldberg Characterization by cyproheptadine of the dopamine-induced contraction in canine isolated arteries J. Pharmacol. Exp. Ther. 193 1975 435 442
163. R Godbout Y Chaput P Blier C de Montigny Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine. I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission Neuropharmacology 30 1991 679 690
164. P.W Gold G.P Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH⧸NE states Mol. Psychiatry 7 2002 254 275
165. R.N Golden D Ekstrom T.M Brown R Ruegg D.L Evans J.J., Jr Haggerty J.C Garbutt C.A Pedersen G.A Mason J Browne Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects Am. J. Psychiatry 149 1992 1168 1175
166. G.M Goodwin R.J De Souza A.R Green D.J Heal The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di- n -propylamino)tetralin (8-OH-DPAT) Psychopharmacology 91 1987 506 511
167. A.E Gordon B.S Meldrum Effect of insulin on brain 5-hydroxytryptamine and 5-hydroxy-indole-acetic acid of rat Biochem. Pharmacol. 19 1970 3042 3044
168. M.V Graf A.J Kastin A.J Fischman Interaction of arginine vasopressin and corticotropin releasing factor demonstrated with an improved bioassay Proc. Soc. Exp. Biol. Med. 179 1985 303 308
169. T.S Gray Amygdaloid CRF pathways: Role in autonomic, neuroendocrine, and behavioral responses to stress Ann. N. Y. Acad. Sci. 697 1993 53 60
170. T.S Gray M.E Carney D.J Magnuson Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: Possible role in stress-induced adrenocorticotropin release Neuroendocrinology 50 1989 433 446
171. T.S Gray R.A Piechowski J.M Yracheta P.A Rittenhouse C.L Bethea L.D Van de Kar Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone Neuroendocrinology 57 1993 517 524
172. C.S Grob R.E Poland L Chang T Ernst Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: Methodological considerations and preliminary observations Behav. Brain Res. 73 1996 103 107
173. C Gundlah M Pecins-Thompson W.E Schutzer C.L Bethea Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus Brain Res. Mol. Brain Res. 63 1999 325 339
174. N Haddjeri G Lucas P Blier Role of cholinergic and GABAergic systems in the feedback inhibition of dorsal raphe 5-HT neurons Neuroreport 11 2000 3397 3401
175. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat Br. J. Pharmacol. 126 1999 1741 1750
176. J Hannibal Neurotransmitters of the retino-hypothalamic tract Cell Tissue Res. 309 2002 73 88
177. M.S Harbuz J Chalmers L De Souza S.L Lightman Stress-induced activation of CRF and c- fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion Brain Res. 609 1993 167 173
178. C Heim D.J Newport R Bonsall A.H Miller C.B Nemeroff Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse Am. J. Psychiatry 158 2001 575 581
179. 2A receptor mediation of the HPA axis Neuropharmacology 42 2002 162 169
180. 2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212 Eur. J. Pharmacol. 311 1996 207 211
181. G.R Heninger P.L Delgado D.S Charney L.H Price G.K Aghajanian Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients J. Chem. Neuroanat. 5 1992 347 348
182. G.R Heninger P.L Delgado D.S Charney The revised monoamine theory of depression: A modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans Pharmacopsychiatry 29 1996 2 11
183. 1A receptor–G protein interactions in brain following chronic antidepressant administration Neuropsychopharmacology 26 2002 565 573
184. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments Neuropsychopharmacology 4 1991 131 144
185. J.R.E Herdman N.J Delva R.E Hockney G.M Campling P.J Cowen Neuroendocrine effects of sumatriptan Psychopharmacology (Berl.) 113 1994 561 564
186. J.P Herman W.E Cullinan Neurocircuitry of stress: Central control of the hypothalamo–pituitary–adrenocortical axis Trends Neurosci. 20 1997 78 84
187. J.P Herman M.K Schafer E.A Young R Thompson J Douglass H Akil S.J Watson Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo–pituitary–adrenocortical axis J. Neurosci. 9 1989 3072 3082
188. J.P Herman W.E Cullinan S.J Watson Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression J. Neuroendocrinol 6 1994 433 442
189. 1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635 Neuropsychopharmacology 24 2001 11 20
190. I Heuser A Yassouridis F Holsboer The combined dexamethasone⧸CRH test: A refined laboratory test for psychiatric disorders J. Psychiatr. Res. 28 1994 341 356
191. R.M Hirschfeld Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs J. Clin. Psychiatry 60 1999 326 335
192. 1A receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo Eur. J. Pharmacol. 316 1996 43 47
193. M.C Holmes K.L French J.R Seckl Modulation of serotonin and glucocorticoid receptor gene expression in the rat hippocampus with circadian rhythm and stress Mol. Brain Res. 28 1995 186 192
194. M.C Holmes J.L.W Yau K.L French J.R Seckl The effect of adrenalectomy on 5-hydroxytryptamine and glucocorticoid receptor subtype messenger RNA expression in rat hippocampus Neuroscience 64 1995 327 337
195. 2C and glucocorticoid receptor gene expression in the hippocampus with food restriction and glucocorticoids J. Neurosci 17 1997 4056 4065
196. F Holsboer Stress, hypercortisolism and glucocorticoid receptors in depression: Implications for therapy J. Affect. Disord. 62 2001 77 91
197. F Holsboer N Barden Antidepressants and hypothalamic pituitary adrenocortical regulation Endocr. Rev. 17 1996 187 205
198. 1 recognition sites J. Receptor Res. 8 1988 59 81
199. D Hoyer G Martin 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome Neuropharmacology 36 1997 419 428
200. D Hoyer D.E Clarke J.R Fozard P.R Hartig G.R Martin E.J Mylecharane P.R Saxena P.P.A Humphrey VIIth International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol. Rev. 46 1994 157 204
201. M Hudson A.J Cleare The 1 μg short Synacthen test in chronic fatigue syndrome Clin. Endocrinol. (Oxf.) 51 1999 625 630
202. P.P.A Humphrey P Hartig D Hoyer A proposed new nomenclature for 5-HT receptors Trends Pharmacol. Sci. 14 1993 233 236
203. 4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells Mol. Brain Res. 10 1991 251 258
204. T Inoue K Tsuchiya T Koyama Serotonergic activation reduces defensive freezing in the conditioned fear paradigm Pharmacol. Biochem. Behav. 53 1996 825 831
205. J Iwata K Chida J.E LeDoux Cardiovascular responses elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthetized rats resemble conditioned emotional responses Brain Res. 418 1987 183 188
206. F.M Jacobsen D.A Sack T.A Wehr S Rogers N.E Rosenthal Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder Arch. Gen. Psychiatry 44 1987 1086 1091
207. L Jacobson R Sapolsky The role of the hippocampus in feedback regulation of the hypothalamic–pituitary–adrenocortical axis Endocr. Rev. 12 1991 118 134
208. H Jorgensen U Knigge A Kjær J Warberg Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds J. Neuroendocrinol 11 1999 283 290
209. B.R Kaada Somato-motor, autonomic and electrocorticographic responses to electrical stimulation of rhinencephalic and other structures in primates, cat and dog, A cortex, and amygdala Acta Physiol. Scand. 24 Suppl. 83 1951 1 285
210. K Kageyama F Tozawa N Horiba H Watanobe T Suda Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats Neurosci. Lett. 243 1998 17 20
211. R.S Kahn G.M Asnis S Wetzler H.M Van Praag Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder Psychopharmacology 96 1988 360 364
212. R.S Kahn O Kalus S Wetzler W Cahn G.M Asnis H.M Van Praag Effects of serotonin antagonists on m -chlorophenylpiperazine-mediated responses in normal subjects Psychiatry Res. 33 1990 189 198
213. R.S Kahn S Wetzler G.M Asnis M.A Kling R.F Suckow H.M Van Praag Effects of m -chlorophenylpiperazine in normal subjects: A dose–response study Psychopharmacology (Berl.) 100 1990 339 344
214. H.O Kalkman G Engel D Hoyer Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats J. Hypertens. Suppl. 2 1984 S143 S145
215. S.P Kalra P.S Kalra Nutritional infertility, the role of the interconnected hypothalamic neuropeptide Y–galanin–opioid network Front. Neuroendocrinol. 17 1996 371 401
216. H Kannan H Yamashita Connections of neurons in the region of the nucleus tractus solitarius with the hypothalamic paraventricular nucleus: Their possible involvement in neural control of the cardiovascular system in rats Brain Res. 329 1985 205 212
217. G.J Kant E.H Mougey L.L Pennington J.L Meyerhoff Graded footshock stress elevates pituitary cyclic AMP and plasma β-endorphin, β-LPH, corticosterone and prolactin Life Sci. 33 1983 2657 2663
218. J.W Kasckow D Baker T.D., Jr Geracioti Corticotropin-releasing hormone in depression and post-traumatic stress disorder Peptides 22 2001 845 851
219. R.G Kathol R Anton R Noyes T Gehris Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder Biol. Psychiatry 25 1989 873 878
220. S Kawano T Osaka H Kannan H Yamashita Excitation of hypothalamic paraventricular neurons by stimulation of the raphe nuclei Brain Res. Bull. 28 1992 573 579
221. M.E Keller-Wood M.F Dallman Glucocorticoid inhibition of ACTH secretion Endocr. Rev. 5 1984 1 24
222. G.A Kennett M.H Joseph The functional importance of increased brain tryptophan in the serotonergic response to restraint stress Neuropharmacology 20 1981 39 43
223. R.C Kessler The effects of stressful life events on depression Annu. Rev. Psychol. 48 1997 191 214
224. R.C Kessler C.B Nelson K.A Mcgonagle J Liu M Swartz D.G Blazer Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey Br. J. Psychiatry Suppl. 30 1996 17 30
225. 1C receptor subtype Neurosci. Lett. 105 1989 174 176
226. L.G Kirby K.C Rice R.J Valentino Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus Neuropsychopharmacology 22 2000 148 162
227. J.Z Kiss M Palkovits L Zaborszky E Tribollet D Szabo G.B Makara Quantitative histological studies on the hypothalamic paraventricular nucleus in rats. II. Number of local and certain afferent nerve terminals Brain Res. 265 1983 11 20
228. O.A Kletzky R.P Marrs J.T Nicoloff Effects of cyproheptadine on insulin-induced hypoglycaemia secretion of PRL, GH and cortisol Clin. Endocrinol. (Oxf.) 13 1980 231 234
229. J.I Koenig G.A Gudelsky H.Y Meltzer Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation Eur. J. Pharmacol 137 1987 1 8
230. 1A receptor-mediated effects of buspirone, gepirone and ipsapirone Pharmacol. Biochem. Behav. 29 1988 711 715
231. J.W Koper R.P Stolk P de Lange N.A Huizenga G.J Molijn H.A Pols D.E Grobbee M Karl F.H de Jong A.O Brinkmann S.W Lamberts Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance Hum. Genet. 99 1997 663 668
232. D.S Kreiss I Lucki Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274 1995 866 876
233. D.T Krieger W Allen F Rizzo H.P Krieger Characterization of the normal temporal pattern of plasma glucocorticoid levels J. Clin. Endocrinol. Metab. 32 1971 266 284
234. M.J Kruesi J Dale S.E Straus Psychiatric diagnoses in patients who have chronic fatigue syndrome J. Clin. Psychiatry 50 1989 53 56
235. D.J Kupfer C.M Bulik D.B Jarrett Nighttime plasma cortisol secretion and EEG sleep—are they associated? Psychiatry Res. 10 1983 191 199
236. 2 receptor-mediated wet-dog shake behaviors Psychopharmacology (Berl.) 108 1992 27 32
237. 2 receptor binding and 5-HT transporter mRNA expression in rat brain Brain Res. 648 1994 157 161
238. G Laakmann M Wittmann M Gugath O.A Mueller J Treusch U Wahlster G.K Stalla Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis Psychopharmacology (Berl.) 84 1984 66 70
239. K.S LaBar J.E LeDoux D.D Spencer E.A Phelps Impaired fear conditioning following unilateral temporal lobectomy in humans J. Neurosci. 15 1995 6846 6855
240. 3H]zacopride as radioligands Synapse 10 1992 271 281
241. J Lavicky A.J Dunn Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis J. Neurochem. 60 1993 602 612
242. M.-C Lebrethon D Naville M Begeot J.M Saez Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II J. Clin. Invest. 93 1994 1828 1833
243. 1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy Psychopharmacology (Berl.) 130 1997 368 374
244. J.E LeDoux Emotion: Clues from the brain Annu. Rev. Psychol. 46 1995 209 235
245. 4 receptor subtype Neuroscience 47 1992 999 1007
246. H Lefebvre V Contesse C Delarue C Soubrane A Legrand J.-M Kuhn L.-M Wolf H Vaudry Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: In vivo and in vitro studies J. Clin. Endocrinol. Metab. 77 1993 1662 1666
247. H Lefebvre V Contesse C Delarue A Legrand J.M Kuhn H Vaudry L.M Wolf The serotonin-4 receptor agonist cisapride and angiotensin-II exert additive effects on aldosterone secretion in normal man J. Clin. Endocrinol. Metab. 80 1995 504 507
248. 4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism Neuroendocrinology 66 1997 229 233
249. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine Neuropharmacology 39 2000 110 122
250. 1A receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge Neuropsychopharmacology 20 1999 628 639
251. 1A receptor responsivity in unipolar depression: Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls Biol. Psychiatry 28 1990 620 628
252. 1A) receptor activation: Effects of 5-HT receptor and β-adrenoceptor antagonists J. Clin. Endocrinol. Metab. 70 1990 670 674
253. N Levin J.L Roberts Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes Front. Neuroendocrinol. 12 1991 1 22
254. N Levin S.F Akana L Jacobson R.W Kuhn P.K Siiteri M.F Dallman Plasma adrenocorticotropin is more sensitive than transcortin production or thymus weight to inhibition by corticosterone in rats Endocrinology 121 1987 1104 1110
255. E.S Levine B.L Jacobs Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: Microiontophoretic studies in the awake cat J. Neurosci. 12 1992 4037 4044
256. 3 receptors in the secretion of prolactin: ACTH and renin Neuroendocrinology 58 1993 65 70
257. 1A agonist J. Pharmacol. Exp. Ther. 279 1996 1035 1042
258. Q Li I Murakami S Stall A.D Levy M.S Brownfield D.E Nichols L.D Van de Kar Neuroendocrine pharmacology of three serotonin releasers, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAI) and p -methylthioamphetamine (MTA) J. Pharmacol. Exp. Ther. 279 1996 1261 1267
259. 1A receptors in the rat brain: Lack of effect by repeated injections of fluoxetine Brain Res. 769 1997 141 151
260. 1A receptors J. Pharmacol. Exp. Ther. 282 1997 1581 1590
261. 1A) in 5-HT transporter knock-out mice: Gender and brain region differences J. Neurosci. 20 2000 7888 7895
262. 1A receptor mRNA in the dentate gyrus of the long-term adrenalectomized rats and rapid reversal by dexamethasone Mol. Brain Res. 19 1993 328 332
263. J.A Lieberman R Brenner M Lesser E Coccaro M Borenstein J.M Kane Dexamethasone suppression tests in patients with panic disorder Am. J. Psychiatry 140 1983 917 919
264. J.A Lieberman J.M Kane S Sarantakos K Cole A Howard M Borenstein H Novacenko J Puig-Antich Dexamethasone suppression tests in patients with obsessive-compulsive disorder Am. J. Psychiatry 142 1985 747 751
265. A.C Linthorst C Flachskamm S.J Hopkins M.E Hoadley M.S Labeur F Holsboer J.M Reul Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge J. Neurosci. 17 1997 4448 4460
266. Z Liposits C Phelix W.K Paull Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat: A light and electron microscopic immunocytochemical study Histochemistry 86 1987 541 549
267. Z Liposits R.M Uht R.W Harrison F.P Gibbs W.K Paull M.C Bohn Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF) Histochemistry 87 1987 407 412
268. I Llorente F Lizcano R Alvarez N Diez M Sopena M.J Gil J Salvador Cholinergic modulation of spontaneous hypothalamic–pituitary–adrenal activity and its circadian variation in man J. Clin. Endocrinol. Metab. 81 1996 2902 2907
269. A.D Loewy Central autonomic pathways A.D Loewy K.M Spyer “Central Regulation of Autonomic Functions” 1990 Oxford University Press New York 88 103
270. A.D Loewy H Burton Nuclei of the solitary tract, efferent projections to the lower brain stem and spinal cord of the cat J. Comp. Neurol. 181 1978 421 449
271. 2) agonists and antagonists on renin and corticosterone secretion Neuroendocrinology 45 1987 305 310
272. 7) implicated in the regulation of mammalian circadian rhythms Neuron 11 1993 449 458
273. C.A Lowry J.D Rose F.L Moore Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian Horm. Behav. 30 1996 50 59
274. C.A Lowry J.E Rodda S.L Lightman C.D Ingram Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: Evidence for activation of a topographically organized mesolimbocortical serotonergic system J. Neurosci. 20 2000 7728 7736
275. C.A Lowry K.A Burke K.J Renner F.L Moore M Orchinik Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus Horm. Behav. 39 2001 195 205
276. M.T Lowy Quantification of type I and II adrenal steroid receptors in neuronal, lymphoid and pituitary tissues Brain Res. 503 1989 191 197
277. M.T Lowy Reserpine-induced decrease in type I and II glucocorticoid receptors in neuronal and lymphoid tissues of adrenalectomized rats Neuroendocrinology 51 1990 190 196
278. 1A receptor binding and G protein activation in female monkeys Neuropsychopharmacology 27 2002 12 24
279. J.V Lucey V O'Keane G Butcher A.W Clare T.G Dinan Cortisol and prolactin responses to d -fenfluramine in non-depressed patients with obsessive-compulsive disorder: A comparison with depressed and healthy controls Br. J. Psychiatry 161 1992 517 521
280. M Maes M De Ruyter R Claes G Bosma E Suy The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients J. Affect. Disord. 13 1987 23 30
281. M Maes M Vandewoude C Schotte L Maes M Martin P Blockx Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients Acta Psychiatr. Scand. 80 1989 584 590
282. M Maes M Vandewoude C Schotte L Maes M Martin S Scharpe P Blockx The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of l -tryptophan in depressed females Biol. Psychiatry 27 1990 601 608
283. S.F Maier C.R Busch S Maswood R.E Grahn L.R Watkins The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM Behav. Neurosci. 109 1995 759 766
284. S.F Maier R.E Grahn S Maswood L.R Watkins The benzodiazepine receptor antagonists flumazenil and CGS8216 block the enhancement of fear conditioning and interference with escape behavior produced by inescapable shock Psychopharmacology (Berl.) 121 1995 250 258
285. G.B Makara E Stark M Karteszi M Palkovits G Rappay Effects of paraventricular lesions on stimulated ACTH release and CRF in stalk-median eminence of the rat Am. J. Physiol. 240 1981 E441 E446
286. M Mas M Farre R de la Torre P.N Roset J Ortuno J Segura J Cami Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans J. Pharmacol. Exp. Ther. 290 1999 136 145
287. 1A receptors and plasma corticosterone levels Gen. Pharmacol. 27 1996 355 361
288. S Matzen N.H Secher U Knigge J Pawelczyk G Perko H Iversen F.W Bach J Warberg Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans Acta Physiol. Scand. 149 1993 163 176
289. S.H Matzen Neuroendocrine mechanisms during reversible hypovolaemic shock in humans with emphasis on the histaminergic and serotonergic system Acta Physiol. Scand. 155 Suppl. 628 1995 1 3
290. R.H McAllister-Williams I.N Ferrier A.H Young Mood and neuropsychological function in depression: The role of glucocorticoids and serotonin Psychol. Med. 28 1998 573 584
291. H.Y Meltzer M Maes Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects Biol. Psychiatry 35 1994 316 323
292. H.Y Meltzer M Maes Effects of ipsapirone on plasma cortisol and body temperature in major depression Biol. Psychiatry 38 1995 450 457
293. H.Y Meltzer M Maes Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men Psychiatry Res. 58 1995 89 98
294. H.Y Meltzer R Perline B.J Tricou M Lowy A Robertson Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms Arch. Gen. Psychiatry 41 1984 379 387
295. H.Y Meltzer B Umberkoman-Wiita A.G Robertson B.J Tricou M Lowy Correction and amplification, cortisol response to 5-HTP Arch. Gen. Psychiatry 43 1986 815
296. H.Y Meltzer B Bastani K Jayathilake M Maes Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder Neuropsychopharmacology 17 1997 1 11
297. 1B receptors in the dorsal hippocampus and cortex of the rat Neuroendocrinology 55 1992 444 450
298. U Meyer M Kruhoffer G Flugge E Fuchs Cloning of glucocorticoid receptor and mineralocorticoid receptor cDNA and gene expression in the central nervous system of the tree shrew ( Tupaia belangeri ) Brain Res. Mol. Brain Res. 55 1998 243 253
299. 2-induced anxiety in patients with panic disorder and normal volunteers Br. J. Psychiatry 176 2000 182 188
300. O.E Millhouse A Golgi study of the descending medial forebrain bundle Brain Res. 15 1969 341 363
301. N Mizuno C.D Clemente E.K Sauerland Fiber projections from rostral basal forebrain structures in the cat Exp. Neurol. 25 1969 220 237
302. S Modell C.J Lauer W Schreiber J Huber J.C Krieg F Holsboer Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders Neuropsychopharmacology 18 1998 253 262
303. F.G Moeller J.M Bjork D.M Dougherty L.D Van de Kar D.M Marsh A.C Swann Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans Psychoneuroendocrinology. 25 2000 607 618
304. M.M Moga C.B Saper Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat J. Comp. Neurol. 346 1994 137 150
305. M.M Moga C.B Saper T.S Gray Bed nucleus of the stria terminalis, cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat J. Comp. Neurol. 283 1989 315 332
306. M.P Moisan J.R Seckl C.R Edwards 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: Localization in hypothalamus, hippocampus, and cortex Endocrinology 127 1990 1450 1455
307. M.E Molliver Serotonergic neuronal systems: What their anatomic organization tells us about function J. Clin. Psychopharmacol. 7 Suppl. 6 1987 3S 23S
308. R.Y Moore Suprachiasmatic nucleus, secondary synchronizing stimuli and the central neural control of circadian rhythms Brain Res. 183 1980 13 28
309. R.Y Moore V.B Eichler Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat Brain Res. 42 1972 201 206
310. W.W Morgan P.K Rudeen K.A Pfeil Effect of immobilization stress on serotonin content and turnover in regions of the rat brain Life Sci. 17 1975 143 150
311. M.C Mormon A Bogdan S Cormont Y Touitou F Levi Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: Relevance for clinical outcome Anticancer Res. 22 2002 1243 1249
312. C Mortimore I.M Anderson d -Fenfluramine in panic disorder: A dual role for 5-hydroxytryptamine Psychopharmacology (Berl.) 149 2000 251 258
313. T Mouri K Itoi K Takahashi T Suda O Murakami K Yoshinaga N Andoh H Ohtani T Masuda N Sasano Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus Neuroendocrinology 57 1993 34 39
314. 1 hippocampal pyramidal cells Neuropsychopharmacology 23 2000 419 427
315. D.L Murphy E.A Mueller J.L Hill T.J Tolliver F.M Jacobsen Comparative anxiogenic, neuroendocrine, and other physiologic effects of m -chlorophenylpiperazine given intravenously or orally to healthy volunteers Psychopharmacology (Berl.) 98 1989 275 282
316. C.B Nemeroff E Widerlov G Bissette H Walleus I Karlsson K Eklund C.D Kilts P.T Loosen W Vale Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients Science 226 1984 1342 1344
317. C.B Nemeroff M.J Owens G Bissette A.C Andorn M Stanley Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims Arch. Gen. Psychiatry 45 1988 577 579
318. 1B receptor mRNA in rat hippocampus Mol. Brain Res. 82 2000 65 73
319. 1A receptor sensitivity in rat hypothalamus and hippocampus, respectively Neuropharmacology 39 2000 2309 2317
320. P.T Ninan The functional anatomy, neurochemistry, and pharmacology of anxiety J. Clin. Psychiatry 60 Suppl. 22 1999 12 17
321. T Noto H Hashimoto Y Doi T Nakajima N Kato Biorhythm of arginine-vasopressin in the paraventricular, supraoptic and suprachiasmatic nuclei of rats Peptides 4 1983 875 878
322. D.J Nutt The psychopharmacology of anxiety Br. J. Hosp. Med. 55 1996 187 191
323. V O'Keane T.G Dinan Prolactin and cortisol responses to d -fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function Am. J. Psychiatry 148 1991 1009 1015
324. V O'Keane D McLoughlin T.G Dinan d -Fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment J. Affect. Disord. 26 1992 143 150
325. 3 pyramidal cells J. Pharmacol. Exp. Ther. 284 1998 1227 1233
326. J.A Olschowka T.L O'Donohue G.P Mueller D.M Jacobowitz Hypothalamic and extrahypothalamic distribution of CRF-like immunoreactive neurons in the rat brain Neuroendocrinology 35 1982 305 308
327. D.S O'Riordain D.R Farley W.F., Jr Young C.S Grant J.A van Heerden Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome Surgery 116 1994 1088 1093
328. A.B Orlikov I.B Prakhye I.V Ryzov Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression Biol. Psychiatry 36 1994 97 102
329. 2 agonist, (±)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic–pituitary–adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain J. Pharmacol. Exp. Ther. 256 1991 787 794
330. K Pacak M Palkovits Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders Endocr. Rev. 22 2001 502 548
331. 1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat Neuroendocrinology 56 1992 797 802
332. C.M Pariante A.H Miller Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment Biol. Psychiatry 49 2001 391 404
333. J.M Paris S.A Lorens L.D Van de Kar J.H Urban K.D Richardson-Morton C.L Bethea A comparison of acute stress paradigms, hormonal responses and hypothalamic serotonin Physiol. Behav. 39 1987 33 43
334. A.J Parker S Wessely A.J Cleare The neuroendocrinology of chronic fatigue syndrome and fibromyalgia Psychol. Med. 31 2001 1331 1345
335. 35S]-GTPγS autoradiography Br. J. Pharmacol. 135 2002 1115 1122
336. A Penhoat C Jaillard J.M Saez Corticotropin positively regulates its own receptors and c-AMP response in cultured bovine adrenal cells Proc. Natl. Acad. Sci. USA 86 1989 4978 4981
337. T Petrov J.H Jhamandas T.L Krukoff Neurochemical characterization of pontine neurons with collaterals to the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus in the rat Soc. Neurosci. Abstr. 18 1992
338. T Petrov T.L Krukoff J.H Jhamandas The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: A combined double retrograde and immunocytochemical study J. Comp. Neurol. 318 1992 18 26
339. T Petrov T.L Krukoff J.H Jhamandas Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat Brain Res. 609 1993 81 92
340. T Petrov T.L Krukoff J.H Jhamandas Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat Cell Tissue Res. 277 1994 289 295
341. C Peyron J.M Petit C Rampon M Jouvet P.H Luppi Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods Neuroscience 82 1998 443 468
342. M.A Pezzone W.-S Lee G.E Hoffman B.S Rabin Induction of c-Fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli Brain Res. 597 1992 41 50
343. 1A receptor challenge in major depression and suicidal behavior Pharmacopsychiatry 28 Suppl. 2 1995 91 92
344. J.W Plonk C.H Bivens J.M Feldman Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine J. Clin. Endocrinol. Metab. 38 1974 836 840
345. P.M Plotsky Pathways to the secretion of adrenocorticotropin: A view from the portal J. Neuroendocrinol 3 1991 1 9
346. R.M Post Transduction of psychosocial stress into the neurobiology of recurrent affective disorder Am. J. Psychiatry 149 1992 999 1010
347. A Poteliakhoff Adrenocortical activity and some clinical findings in acute and chronic fatigue J. Psychosom. Res. 25 1981 91 95
348. A.C Power P.J Cowen Neuroendocrine challenge tests: Assessment of 5-HT function in anxiety and depression Mol. Aspects Med. 13 1992 205 220
349. R.W.G Prescott P Kendall-Taylor D.R Weightman M.J Watson The effect of ketanserin: A specific serotonin antagonist on the PRL, GH, ACTH, and cortisol responses to hypoglycaemia in normal subjects Clin. Endocrinol. 20 1984 137 142
350. C.M.F Prewitt J.P Herman Anatomical interactions between the central amygdaloid nucleus and the hypothalamic paraventricular nucleus of the rat: A dual tract-tracing analysis J. Chem. Neuroanat. 15 1998 173 185
351. M.L Price I Lucki Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor J. Neurosci. 21 2001 2833 2841
352. M.L Price A.L Curtis L.G Kirby R.J Valentino I Lucki Effects of corticotropin-releasing factor on brain serotonergic activity Neuropsychopharmacology 18 1998 492 502
353. 1B⧸1D agonist zolmitriptan (311C90, Zomig) Cephalalgia 17 1997 849 854
354. 1A receptor agonist 8-hydroxy-2-(di- n -propylamino)tetralin (8-OH-DPAT) in the rat Pharmacol. Biochem. Behav. 33 1989 329 334
355. F.C Raadsheer A.A Sluiter R Ravid F.J Tilders D.F Swaab Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus: Age-dependent colocalization with vasopressin Brain Res. 615 1993 50 62
356. F.C Raadsheer W.J.G Hoogendijk F.C Stam F.J.H Tilders D.F Swaab Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients Neuroendocrinology 60 1994 436 444
357. D.K Raap L.D Van de Kar Selective serotonin reuptake inhibitors and neuroendocrine function Life Sci. 65 1999 1217 1235
358. i proteins J. Pharmacol. Exp. Ther. 288 1999 98 106
359. i3 proteins in the hypothalamus Neuropharmacology 39 2000 1823 1832
360. G Raisman K Brown-Grant The “suprachiasmatic syndrome”: Endocrine and behavioural abnormalities following lesions of the suprachiasmatic nuclei in the female rat Proc. R. Soc. Lond. B Biol. Sci. 198 1977 297 314
361. R.M Rapee T.A Brown M.M Antony D.H Barlow Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders J. Abnorm. Psychol. 101 1992 538 552
362. M.M Rapport Serum vasoconstrictor (serotonin). V. The presence of creatinine in the complex: A proposed structure of the vasoconstrictor principle J. Biol. Chem. 178 1949 961 969
363. M.M Rapport A.A Green I.H Page Serum vasoconstrictor (serotonin). IV. Isolation and characterization J. Biol. Chem. 176 1948 1234 1251
364. Q.R Regestein W.J Jackson H.F Peterson Effects of various hippocampal lesions on monkey plasma cortisol levels in two experimental conditions Behav. Neural Biol. 45 1986 329 341
365. C Reist D Helmeste L Albers H Chhay S.W Tang Serotonin indices and impulsivity in normal volunteers Psychiatry Res. 60 1996 177 184
366. J.M Reul F Holsboer Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression Curr. Opin. Pharmacol. 2 2002 23 33
367. J.M Reul E.R De Kloet Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation Endocrinology 117 1985 2505 2511
368. J.M Reul M.S Labeur D.E Grigoriadis E.B de Souza F Holsboer Hypothalamic–pituitary–adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide Neuroendocrinology 60 1994 509 519
369. 1A agonist, in three stress paradigms: Immobilization, forced swim and conditioned fear Brain Res. 580 1992 205 214
370. P.A Rittenhouse Q Li A.D Levy L.D Van de Kar Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion Brain Res. 593 1992 105 113
371. 1C⧸2 receptors Endocrinology 133 1993 661 667
372. 2A⧸2C) receptors J. Pharmacol. Exp. Ther. 271 1994 1647 1655
373. C Rivier W Vale Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin Nature 305 1983 325 327
374. o proteins in dorsal raphe nucleus Eur. J. Pharmacol. 265 1994 103 106
375. W.H Rotsztejn A Beaudet A.G Rpberge J Lalonde C Fortier Role of brain serotonin in the circadian rhythm of corticosterone secretion and the corticotropic response to adrenalectomy in the rat Neuroendocrinology 23 1977 157 170
376. P.P Roy-Byrne T.W Uhde R.M Post W Gallucci G.P Chrousos P.W Gold The corticotropin-releasing hormone stimulation test in patients with panic disorder Am. J. Psychiatry 143 1986 896 899
377. 7) activating c-AMP formation Proc. Natl. Acad. Sci. USA 90 1993 8547 8551
378. R.T Rubin A.J Mandell P.H Crandall Glucocorticoid responses to limbic stimulation in man: Localization of stimulus sites Science 153 1966 767 768
379. J.A Russell G Leng R.J Bicknell Opioid tolerance and dependence in the magnocellular oxytocin system: A physiological mechanism Exp. Physiol. 80 1995 307 340
380. M Sakanaka T Shibasaki K Lederis Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method J. Comp. Neurol. 260 1987 256 298
381. 1A agonist, 8-hydroxy-2-(di- n -propylamino)tetralin on neurochemical responses to stress J. Neurochem. 64 1995 767 776
382. R.M Sapolsky L.C Krey B.S McEwen Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response Proc. Natl. Acad. Sci. USA 81 1984 6174 6177
383. R.M Sapolsky S Zola-Morgan L.R Squire Inhibition of glucocorticoid secretion by the hippocampal formation in the primate J. Neurosci. 11 1991 3695 3704
384. R.M Sapolsky L.M Romero A.U Munck How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocr. Rev. 21 2000 55 89
385. 1A receptor sensitivity Psychopharmacology (Berl.) 132 1997 296 302
386. P.E Sawchenko L.W Swanson The organization and biochemical specificity of afferent projections to the paraventricular and supraoptic nuclei Prog. Brain Res. 60 1983 19 29
387. P.E Sawchenko L.W Swanson The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat J. Comp. Neurol. 218 1983 121 144
388. P.E Sawchenko L.W Swanson H.W.M Steinbusch A.A.J Verhofstad The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat Brain Res. 277 1983 355 360
389. P.E Sawchenko L.W Swanson W.W Vale Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat Proc. Natl. Acad. Sci. USA 81 1984 1883 1887
390. P.E Sawchenko L.W Swanson W.W Vale Corticotropin-releasing factor, co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat J. Neurosci. 4 1984 1118 1129
391. P.E Sawchenko T Imaki W Vale Co-localization of neuroactive substances in the endocrine hypothalamus Ciba Found. Symp. 168 1992 16 30
392. U Scapagnini P Preziosi Role of brain norepinephrine and serotonin in the tonic and phasic regulation of hypothalamic hypophyseal adrenal axis Arch. Int. Pharmacodyn. Ther. 196 Suppl. 1972
393. U Scapagnini G.P Moberg G.R Van Loon J De Groot W.F Ganong Relation of brain 5-HT content to the diurnal variation in plasma corticosterone in the rat Neuroendocrinology 7 1971 90 96
394. J.C Schadt J Ludbrook Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals Am. J. Physiol. Heart Circ. Physiol. 260 1991 H305 H318
395. F.E Scheepers C.C Gespen de Wied R.S Kahn The effect of olanzapine treatment on m -chlorophenylpiperazine-induced hormone release in schizophrenia J. Clin. Psychopharmacol 21 2001 575 582
396. L.E Scheving W.H Harrison P Gordon J.E Pauly Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain Am. J. Physiol. 214 1968 166 173
397. K Schruers T Klaassen H Pols T Overbeek N.E Deutz E Griez Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients Psychiatry Res. 93 2000 179 187
398. 1A receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects Psychiatry Res. 86 1999 9 28
399. L.V Scott T.G Dinan Urinary free cortisol excretion in chronic fatigue syndrome: Major depression and in healthy volunteers J. Affect. Disord. 47 1998 49 54
400. L.V Scott S Medbak T.G Dinan The low dose ACTH test in chronic fatigue syndrome and in health Clin. Endocrinol. (Oxf.) 48 1998 733 737
401. J.P Seibyl J.H Krystal L.H Price S.W Woods C D'Amico G.R Heninger D.S Charney Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects Psychiatry Res. 38 1991 227 236
402. H Selye A syndrome produced by diverse nocuous agents Nature 138 1936 32
403. 1A receptors in vivo J. Neurosci. 20 2000 3095 3103
404. 1A receptors in hypothalamus J. Pharmacol. Exp. Ther. 294 2000 296 301
405. M Sharpe A Clements K Hawton A.H Young P Sargent P.J Cowen Increased prolactin response to buspirone in chronic fatigue syndrome J. Affect. Disord. 41 1996 71 76
406. M Sharpe K Hawton A Clements P.J Cowen Increased brain serotonin function in men with chronic fatigue syndrome Br. Med. J. 315 1997 164 165
407. D.V Sheehan J.B Claycomb O.S Surman L Baer J Coleman L Gelles Panic attacks and the dexamethasone suppression test Am. J. Psychiatry 140 1983 1063 1064
408. 7 serotonin receptor subtype J. Biol. Chem. 268 1993 18200 18204
409. N Shimizu Y Oomura Y Kai Stress-induced anorexia in rats mediated by serotonergic mechanisms in the hypothalamus Physiol. Behav. 46 1989 835 841
410. B Shopsin S Gershon M Goldstein E Friedman S Wilk Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients Psychopharmacology 1 1975 239 249
411. B Shopsin E Friedman S Gershon Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients Arch. Gen. Psychiatry 33 1976 811 891
412. A receptors Curr. Top. Med. Chem. 2 2002 833 839
413. A.J Silverman D.L Hoffman E.A Zimmerman The descending afferent connections of the paraventricular nucleus of the hypothalamus Brain Res. Bull. 6 1981 47 61
414. 1A receptor-activated G-proteins in rat brain following chronic buspirone Eur. J. Pharmacol. 389 2000 147 153
415. 7 receptor binding sites in rat hypothalamus: Sensitivity to chronic antidepressant treatment Mol. Pharmacol. 47 1995 99 103
416. M.A Slusher J.E Hyde Effect of limbic stimulation on release of glucocorticoids into the adrenal venous effluent of the cat Endocrinology 69 1961 1080 1084
417. G.P Smith A.W Root Dissociation of changes in growth hormone and adrenocortical hormone levels during brain stimulation of monkeys Neuroendocrinology 8 1971 235 244
418. M.A Smith J Davidson J.C Ritchie H Kudler S Lipper P Chappell C.B Nemeroff The corticotropin-releasing hormone test in patients with posttraumatic stress disorder Biol. Psychiatry 26 1989 349 355
419. R.L Spencer P.J Kim B.A Kalman M.A Cole Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic–pituitary–adrenal axis activity Endocrinology 139 1998 2718 2726
420. M.B Stein R Yehuda C Koverola C Hanna Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse Biol. Psychiatry 42 1997 680 686
421. H.W.M Steinbusch Distribution of serotonin-immunoreactivity in the central nervous system of the rat—cell bodies and terminals Neuroscience 6 1981 557 618
422. M Steiner L.N Yatham M Coote A Wilkins P Lepage Serotonergic dysfunction in women with pure premenstrual dysphoric disorder, is the fenfluramine challenge test still relevant? Psychiatry Res. 87 1999 107 115
423. L.T Stevens F.S Lee Action of intermittent pressure and of defibrinated blood upon blood vessels of frog and terrapin Johns Hopkins Biol. Studies. 3 1884 99
424. C.A Stone H.C Wenger C.T Ludden J.M Stravorski C.A Ross Antiserotonin-antihistaminic properties of cyproheptadine J. Pharmacol. Exp. Ther. 131 1961 84
425. T Suda N Tomori F Yajima T Ushiyama T Sumitomo Y Nakagami H Demura K Shizume A short negative feedback mechanism regulating corticotropin-releasing hormone release J. Clin. Endocrinol. Metab. 64 1987 909 913
426. R.E Sutton G.F Koob M Le Moal J Rivier W Vale Corticotropin releasing factor produces behavioural activation in rats Nature 297 1982 331 333
427. D.F Swaab C.W Pool Specificity of oxytocin and vasopressin immunofluorescence J. Endocrinol. 66 1975 263 272
428. L.W Swanson W.M Cowan The efferent connections of the suprachiasmatic nucleus of the hypothalamus J. Comp. Neurol. 160 1975 1 12
429. L.W Swanson P.E Sawchenko J Rivier W.W Vale Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study Neuroendocrinology 36 1983 165 186
430. A Szafarczyk G Ixart F Malaval J Nouguier-Soule I Assenmacher Effects of lesions of the suprachiasmatic nuclei and of p -chlorophenylalanine on the circadian rhythms of adrenocorticotrophic hormone and corticosterone in the plasma, and on locomotor activity of rats J. Endocrinol. 83 1979 1 16
431. 2 receptor binding and on the receptor-mediated behavioral responses of rats Eur. J. Pharmacol. 333 1997 123 128
432. R Tao S.B Auerbach Regulation of serotonin release by GABA and excitatory amino acids J. Psychopharmacol. 14 2000 100 113
433. B receptors in midbrain raphe nuclei and forebrain of rats Br. J. Pharmacol. 119 1996 1375 1384
434. 1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: An autoradiographic analysis Psychopharmacology (Berl.) 113 1994 481 486
435. K.B Thor C.J Helke Serotonin- and substance P-containing projections to the nucleus tractus solitari of the rat J. Comp. Neurol. 265 1987 275 293
436. L Traskman G Tybring M Asberg L Bertilsson O Lantto D Schalling Cortisol in the CSF of depressed and suicidal patients Arch. Gen. Psychiatry 37 1980 761 767
437. C.M Turkelson C.R Thomas A Arimura D Chang J.K Chang M Shimizu In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin Peptides 3 1982 111 113
438. B.M Twarog I.H Page Serotonin content of some mammalian tissues and urine and a method for its determination Am. J. Physiol. 175 1953 157 161
439. J.H Urban L.D Van de Kar S.A Lorens C.L Bethea Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats Pharmacol. Biochem. Behav. 25 1986 457 462
440. K Uryu T Okumura T Shibasaki M Sakanaka Fine structure and possible origins of nerve fibers with corticotropin-releasing factor-like immunoreactivity in the rat central amygdaloid nucleus Brain Res. 577 1992 175 179
441. A Vahabzadeh M Fillenz Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis Eur. J. Neurosci. 6 1994 1205 1212
442. R.J Valentino L Liouterman E.J Van Bockstaele Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus J. Comp. Neurol. 435 2001 450 463
443. E Van Cauter O.M Buxton Circadian modulation of endocrine secretion J.S Takahashi F.W Turek R.Y Moore “Handbook of Behavioral Neurobiology” 2001 Kluwer Academic⧸Plenum Publishers New York 685 709
444. L.D Van de Kar M.L Blair Forebrain pathways mediating stress-induced hormone secretion Front. Neuroendocrinol. 20 1999 1 48
445. L.D Van de Kar S.A Lorens Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median raphe nuclei Brain Res. 162 1979 45 54
446. L.D Van de Kar S.A Lorens A Vodraska G Allers M Green L.S Van Orden Effect of selective midbrain and diencephalic 5,7-dihydroxytryptamine lesions on serotonin content in individual preopticohypothalamic nuclei and on serum luteinizing hormone level Neuroendocrinology 31 1980 309 315
447. L.D Van de Kar R.A Piechowski P.A Rittenhouse T.S Gray Amygdaloid lesions, differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion Neuroendocrinology 54 1991 89 95
448. L.D Van de Kar K.D Richardson Morton P.A Rittenhouse Stress, neuroendocrine and pharmacological mechanisms G Jasmin M Cantin “Stress Revisited. 1. Neuroendocrinology of Stress: Methods and Achievements in Experimental Pathology” 1991 S. Karger Basel 133 173
449. L.D Van de Kar P.A Rittenhouse Q Li A.D Levy M.S Brownfield Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion Brain Res. Bull. 36 1995 45 50
450. 2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells J. Neurosci. 21 2001 3572 3579
451. F.W Van Leeuwen D.F Swaab C de Raay Immunoelectron microscopic localization of vasopressin in the rat suprachiasmatic nucleus Cell Tissue Res. 193 1978 1 10
452. V Varga A.D Székely A Csillag T Sharp M Hajós Evidence for a role of GABA interneurones in the cortical modulation of midbrain 5-hydroxytryptamine neurones Neuroscience 106 2001 783 792
453. H.D Veldhuis C Van Koppen M Van Ittersum E.R De Kloet Specificity of the adrenal steroid receptor system in rat hippocampus Endocrinology 110 1982 2044 2051
454. A.N Vgontzas E.O Bixler A.M Wittman K Zachman H.M Lin A Vela-Bueno A Kales G.P Chrousos Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men, clinical implications J. Clin. Endocrinol. Metab. 86 2001 1489 1495
455. A Vicentic Q Li G Battaglia L.D Van de Kar WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH, and corticosterone, but not prolactin secretion Eur. J. Pharmacol. 346 1998 261 266
456. U von Bardeleben F Holsboer Cortisol response to a combined dexamethasone–human corticotrophin-releasing hormone challenge in patients with depression J. Neuroendocrinol. 1 1989 485 488
457. U von Bardeleben A Steiger A Gerken F Holsboer Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls Int. Clin. Psychopharmacol. 4 Suppl. 1 1989 1 5
458. D.M Wallace D.J Magnuson T.S Gray Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat Brain Res. Bull. 28 1992 447 454
459. T Watabe K Tanaka M Kumagae S Itoh F Takeda K Morio M Hasegawa T Horiuchi S Miyabe N Shimizu Hormonal responses to insulin-induced hypoglycemia in man J. Clin. Endocrinol. Metab. 65 1987 1187 1191
460. J Weidenfeld A.P Corcos A Wohlman S Feldman Characterization of the 2-deoxyglucose effect on the adrenocortical axis Endocrinology 134 1994 1924 1931
461. N Weiner H.W Clement D Gemsa W Wesemann Circadian and seasonal rhythms of 5-HT receptor subtypes: Membrane anisotropy and 5-HT release in hippocampus and cortex of the rat Neurochem. Int. 21 1992 7 14
462. J.E Welch D Saphier Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane J. Pharmacol. Exp. Ther. 270 1994 918 928
463. K.L Weller D.A Smith Afferent connections to the bed nucleus of the stria terminalis Brain Res. 232 1982 255 270
464. J.H Welsh Serotonin as a possible neurohumoral agent: Evidence obtained in lower animals Ann. N. Y. Acad. Sci. 66 1957 618 630
465. H.G Westenberg H.M Van Praag J.T de Jong J.H Thijssen Postsynaptic serotonergic activity in depressive patients: Evaluation of the neuroendocrine strategy Psychiatry Res. 7 1982 361 371
466. 1D receptors? Psychopharmacology 145 1999 223 226
467. M.H Whitnall Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats J. Comp. Neurol. 275 1988 13 28
468. J.H Williams V.M Miall-Allen M Klinowski E.C Azmitia Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels Neuroendocrinology 36 1983 431 435
469. 2 receptor subtype mRNAs in rat brain J. Comp. Neurol. 351 1995 357 373
470. M.A Yantis Identifying depression as a symptom of sleep apnea J. Psychosoc. Nurs. Ment. Health Serv. 37 1999 28 34
471. F.E Yates S.M Russell M.F Dallman G.A Hodge S.M McCann A.P Dhariwal Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor Endocrinology 88 1971 3 15
472. L.N Yatham R.L Morehouse B.T Chisholm D.A Haase D.D MacDonald T.J Marrie Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome Can. J. Psychiatry 40 1995 93 96
473. 7 receptor gene expression in the rat hippocampus Mol. Brain Res. 45 1997 182 186
474. R Yehuda M.T Lowy S.M Southwick D Shaffer E.L Giller Jr. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder Am. J. Psychiatry 148 1991 499 504
475. R Yehuda S.M Southwick J.H Krystal D Bremner D.S Charney J.W Mason Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder Am. J. Psychiatry 150 1993 83 86
476. R Yehuda D Boisoneau M.T Lowy E.L., Jr Giller Dose–response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder Arch. Gen. Psychiatry 52 1995 583 593
477. 1A receptors J. Clin. Psychopharmacol. 10 Suppl. 1990 6S 12S
478. E.A Young J.F Lopez V Murphy-Weinberg S.J Watson H Akil The role of mineralocorticoid receptors in hypothalamic–pituitary–adrenal axis regulation in humans J. Clin. Endocrinol. Metab. 83 1998 3339 3345
479. Y Zhang D.K Raap F Garcia F Serres Q Ma G Battaglia L.D Van de Kar Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats Brain Res. 855 2000 58 66
480. 2A receptor activation J. Neurosci. 21 2001 7919 7927
481. 2A receptors in the hypothalamic paraventricular nucleus mediate the neuroendocrine effects of (–)DOI J. Neurosci. 22 2002 9635 9642
482. J Zohar H.G Westenberg Anxiety disorders, a review of tricyclic antidepressants and selective serotonin reuptake inhibitors Acta Psychiatr. Scand. Suppl. 403 2000 39 49
483. J Zohar E.A Mueller T.R Insel R.C Zohar-Kadouch D.L Murphy Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls Arch. Gen. Psychiatry 44 1987 946 951